Drug Shortage Report for APO-NAPROXEN
Report ID | 16881 |
Drug Identification Number | 00592277 |
Brand name | APO NAPROXEN TAB 500MG |
Common or Proper name | NAPROXEN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | NAPROXEN |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 BTL |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-12-18 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-11-08 |
Shortage status | Avoided shortage |
Updated date | 2017-11-09 |
Company comments | 100 BTL available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2017-11-09 | French | Compare |
v7 | 2017-11-09 | English | Compare |
v6 | 2017-10-10 | French | Compare |
v5 | 2017-10-10 | English | Compare |
v4 | 2017-09-22 | French | Compare |
v3 | 2017-09-22 | English | Compare |
v2 | 2017-07-25 | French | Compare |
v1 | 2017-07-25 | English | Compare |
Showing 1 to 8 of 8